To provide support for scaling up global access to multiple micronutrient supplements and other cost effective maternal and child interventions, and for other purposes.

119th Congress Introduced by Young Kim and 2 co-sponsors

The bill would expand U.S. funding and programs to scale up multiple micronutrient supplements for pregnant women and young children in low- and middle-income countries.

Introduced in House

Summary of HR 9583 (119th Congress)

Purpose and objective

HR 9583 aims to support scaling up global access to multiple micronutrient supplements (MMS) and other cost-effective maternal and child health interventions.

The bill’s overarching goal is to improve maternal and child health outcomes by expanding availability, affordability, and integration of evidence-based micronutrient and related interventions in low- and middle-income countries, with a focus on maternal and child nutrition.

Key provisions and changes (highlights)

Support for scaling up MMS programs: Authorization or encouragement of efforts to increase production, procurement, distribution, and use of multiple micronutrient supplements for pregnant women and young children.

Funding and financing mechanisms (potential): The bill likely authorizes appropriations or directs federal agencies to mobilize funds, grants, or public–private partnerships to expand MMS access and strengthen supply chains.

Integration with other interventions: Emphasis on coupling MMS with complementary maternal and child health interventions (e.g., nutrition education, supplementation programs, immunization, prenatal care) to maximize impact.

Global health focus: Targets international programs and partnerships to advance MMS uptake and related health outcomes in low-resource settings.

Monitoring and reporting: Provisions may require oversight, performance metrics, and reporting to U.S. Congress on progress, funding use, and impact indicators.

Coordination and governance: Encourages collaboration among relevant U.S. agencies (e.g., USAID, State Department, Department of Health and Human Services) and international partners to implement scale-up activities efficiently.

Who/what would be affected

Beneficiaries: Pregnant women, newborns, infants, and young children in low- and middle-income countries who would benefit from improved access to MMS and other maternal-child health interventions.

U.S. agencies: Federal agencies involved in international health, nutrition, and development assistance would implement or administer programs, grants, and coordination efforts.

Partners and stakeholders: International organizations, non-governmental organizations, private sector providers, and country governments engaged in nutrition and maternal-child health programs.

Procedural and timeline aspects

Sponsorship: Introduced in the House with co-sponsors Mike Lawler, Young Kim, and Dina Titus.

Referral: Referred to the House Committee on Foreign Affairs on July 2, 2026.

Next steps: Committee consideration, potential markup, and floor debate/vote would follow, contingent on committee action and legislative priorities. Any appropriations or authorizations would align with the committee’s budget and foreign affairs agenda for the 118th–119th Congress session.

Practical implications

If enacted, the bill could expand U.S. funding and technical support for MMS scale-up, potentially improving maternal and child nutrition indicators (e.g., anemia reduction, birth outcomes) in target countries.

Success depends on effective implementation, supply chain reliability, partner coordination, and sustained funding levels.

Note: This summary reflects the bill’s stated aims and typical framework based on the bill’s title and available action history. For precise language, exact provisions, and final legislative text, consult the official bill document and subsequent committee reports.